logo
Plus   Neg
Share
Email

Roche Q1 Sales Up 9%; Raises FY Outlook

Swiss drug major Roche (RHHBY) reported that its group sales for the first-quarter rose 9 percent to 14.83 billion Swiss francs from last year's 13.58 billion francs, while it was up 8 percent at constant exchange rates. The company raised outlook for 2019.

Sales in the Pharmaceuticals Division increased 10% to 11.9 billion francs. The growth drivers were the multiple sclerosis medicine Ocrevus and cancer medicines Perjeta and Tecentriq as well as the new haemophilia medicine Hemlibra. The strong uptake of newly introduced medicines was partially offset by lower sales of Herceptin and of MabThera/Rituxan, the company said.

In the US, sales increased 14%, led by Ocrevus, Hemlibra, Perjeta and Tecentriq. Ocrevus sales were driven by both new and continuing patient demand.

For 2019, Roche now expects sales to grow in the mid-single digit range, at constant exchange rates. Core earnings per share are targeted to grow broadly in line with sales, at constant exchange rates. It expects to further increase its dividend in Swiss francs.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Volvo Cars issued a recall for 507,000 vehicles worldwide, citing a risk of fire due to a faulty engine component. The Swedish automaker reportedly said it has received reports of a small number of cars catching fire, but no one has been injured. The recall could affect certain vehicles produced during the period from 2014 to 2019 and having two-liter, four-cylinder diesel engines. Auction house Sotheby's said on the 50th anniversary of the Apollo 11 lunar landing, it has auctioned the three original videotape recordings depicting the event for $1.82 million in New York. The price is more than 8,000 times the price paid for the tapes by then-NASA intern Gary George at a government surplus auction in 1976. Apollo 11 was the spaceflight that first landed humans on the moon. Equifax Inc. (EFX) announced Monday a comprehensive resolution of significant U.S. consumer-related litigation and regulatory matters facing the company related to its 2017 cybersecurity incident. Equifax has been providing free credit monitoring services to consumers since September 2017. The $671...
Follow RTT